Cargando…
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras
We previously demonstrated activation of the mitogen-activated protein kinase (MAPK) pathway in a series of romidepsin-selected T-cell lymphoma cell lines as a mechanism of resistance to the histone deacetylase inhibitor (HDI), romidepsin. As Ras mutation leads to activation of both the MAPK and the...
Autores principales: | Bahr, Julian C., Robey, Robert W., Luchenko, Victoria, Basseville, Agnes, Chakraborty, Arup R., Kozlowski, Hanna, Pauly, Gary T., Patel, Paresma, Schneider, Joel P., Gottesman, Michael M., Bates, Susan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340114/ https://www.ncbi.nlm.nih.gov/pubmed/27634878 http://dx.doi.org/10.18632/oncotarget.12001 |
Ejemplares similares
-
R-Loop–Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
por: Safari, Maryam, et al.
Publicado: (2021) -
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated Cells
por: Basseville, Agnes, et al.
Publicado: (2022) -
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
por: Sears, Thomas K., et al.
Publicado: (2021) -
Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer
por: Zhang, Xiaofei, et al.
Publicado: (2022) -
Gout, genetics and ABC transporters
por: Basseville, Agnès, et al.
Publicado: (2011)